Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

26.65
Delayed Data
As of Feb 27
 +1.35 / +5.34%
Today’s Change
12.15
Today|||52-Week Range
27.95
+5.54%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close25.30
Today’s open25.35
Day’s range25.15 - 26.81
Volume478,948
Average volume (3 months)499,162
Market cap$1.3B
Dividend yield--
Data as of 02/27/2017

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+225.00%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio16.6
Price/Sales4.76
Price/Book10.99

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+1.15+3.18%
INVAInnoviva Inc+0.42+3.66%
FWPForward Pharma A/S-0.46-1.64%
ACORAcorda Therapeutics ...+2.50+10.04%
Data as of 02/27/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs